Showing results (61-70 of 279) with videos related to
Sort By:
Pageof 28
Cell|October 16, 2012
Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AMLThanh-Trang Vo, Jeremy Ryan, Ruben Carrasco, et al.Blood Advances|January 24, 2025
Clinical use of measurable residual disease in adult ALL: recommendations from a panel of US expertsNicholas J Short, Ibrahim Aldoss, Daniel J DeAngelo, et al.Leukemia Research|June 11, 2013
Geriatric assessment in older patients with acute myeloid leukemia: a retrospective study of associated treatment and outcomesAlexander E Sherman, Gabriela Motyckova, K Rebecca Fega, et al.Leukemia Research|February 14, 2014
A phase II study of the EGFR inhibitor gefitinib in patients with acute myeloid leukemiaDaniel J Deangelo, Donna Neuberg, Philip C Amrein, et al.Haematologica|August 10, 2023
Use, variability, and justification of eligibility criteria for phase II and III clinical trials in acute leukemiaAndrew Hantel, Marlise R Luskin, Irum Khan, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2010
NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic malignanciesEdwin P Alyea, Daniel J DeAngelo, Jeffrey Moldrem, et al.Cell Reports|December 22, 2015
RECQL5 Suppresses Oncogenic JAK2-Induced Replication Stress and Genomic InstabilityEdwin Chen, Jong Sook Ahn, David B Sykes, et al.Cancer|October 27, 2020
Phase 1 study to evaluate Crenigacestat (LY3039478) in combination with dexamethasone in patients with T-cell acute lymphoblastic leukemia and lymphomaGautam Borthakur, Giovanni Martinelli, Emmanuel Raffoux, et al.Cancer Chemotherapy and Pharmacology|August 2, 2008
A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804Richard M Stone, Kathleen A Donohue, Wendy Stock, et al.Current Medical Research and Opinion|April 29, 2011
Comparative efficacy of nilotinib and dasatinib in newly diagnosed chronic myeloid leukemia: a matching-adjusted indirect comparison of randomized trialsJames E Signorovitch, Eric Q Wu, Keith A Betts, et al.Pageof 28